Close Menu

NEW YORK (GenomeWeb) – SQream Technologies said today that it has raised $7.4 million in private funding , which it will use to grow its business, particularly in North America.

San Francisco-based Blumberg Capital led the funding With the investment, Alon Lifshitz, a partner at Blumberg Capital, will join SQream's board of directors. To date, SQream has raised $11 million from investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.